Company Legal Name
Latest Valuation
Founded Year
Headquarter
AI21 Labs develops enterprise-grade large language models that power developer tools and writing software solutions. Founded in 2017 and headquartered in Tel Aviv-Yafo, Israel, the company positions itself as a provider of advanced AI language technology for business applications. AI21 Labs has established itself in the competitive LLM market by focusing on practical, enterprise-ready implementations rather than consumer-facing products. The company's platform enables developers and organizations to integrate sophisticated natural language processing capabilities into their workflows and applications. AI21 Labs continues to advance its core language model technology while expanding its suite of professional writing and development tools.
Revenue & Revenue Growth Share
Revenue
Revenue Growth
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.





